Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
Clinical trial NCT02303366 · COMPLETED
Trial details
- NCT number
- NCT02303366
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.